StockWatch
·

JAGSONPAL PHARMACEUTICALS LTD.

BSE: 507789

Shareholding Trends

Ownership split

PromoterPublicOthers
0%26%52%77%Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27

Institutional detail

FII / FPIDII
0%1%2%3%Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27

Q1 FY27

Corporate Events

Board MeetingJAGSNPHARM
2026
28Oct

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing ↗
Board MeetingJAGSNPHARM
2026
18Sep

Board Meeting

The 47th Annual General Meeting (AGM) of Jagsonpal Pharmaceu…

BSE Filing ↗
DividendJAGSNPHARM
2026
4Sep

₹4 / share

BSE Filing ↗
Board MeetingJAGSNPHARM
2026
29Jul

Board Meeting

The meeting of the Board of Directors is scheduled to be hel…

BSE Filing ↗
Board MeetingJAGSNPHARM
2026
25Jun

Board Meeting

The Board of Directors considered and approved the appointme…

BSE Filing ↗
Board MeetingJAGSNPHARM
2026
25Jun

Board Meeting

The Board of Directors considered and approved the appointme…

BSE Filing ↗
Board MeetingJAGSNPHARM
2026
27Apr

Board Meeting

The Board of Directors recommended a dividend of Rs. 4/- pe…

BSE Filing ↗
Board MeetingJAGSNPHARM
2026
12Mar

Board Meeting

To consider and approve the proposal for Buyback of its full…

BSE Filing ↗
Board MeetingJAGSNPHARM
2026
9Mar

Board Meeting

Approval for the grant of employee stock options under Jagso…

BSE Filing ↗
Stock SplitJAGSNPHARM
2025
8Jan

2

BSE Filing ↗
Board MeetingJAGSNPHARM
2024
23Oct

Board Meeting

Unaudited Financial Results of the Company for the quarter a…

BSE Filing ↗
Board MeetingJAGSNPHARM
2024
2Feb

Board Meeting

Consider and approve Unaudited Financial Results of the Comp…

BSE Filing ↗
Board MeetingJAGSNPHARM
2023
3Nov

Board Meeting

Consider and approve the Unaudited Financial Results

BSE Filing ↗